In fact, early in the COVID-19 pandemic, a research team showed that a CRISPR system could degrade coronavirus and influenza genomes in our lung cells.
Al principio de la pandemia de COVID-19, un grupo de investigación mostró que un CRISPR podría degradar genomas de coronavirus e influenza en las células pulmonares.